Dapagliflozin 10 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8QD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,362
Award facts
- Contract value 100% obligated
- $1,362.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.15 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units), with an ultimate completion date of December 24, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant presence in federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The parent SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for Dapagliflozin, a diabetes management medication, exemplifies the routine pharmaceutical fulfillment conducted under this strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FY8QD?
SPE2DR26FY8QD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FY8QD worth?
The government has obligated $1,362 on SPE2DR26FY8QD.
Is contract SPE2DR26FY8QD an order under another contract?
Yes. SPE2DR26FY8QD is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8QD competed?
The extent of competition for SPE2DR26FY8QD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award